Press Release – 15.11.2017

Theraclion and Lead Investigator Presented Preliminary Results of Echotherapy In the Treatment of Varicose Veins

 
These results concern the first study worldwide on the treatment with High Intensity Focused Ultrasound of insufficient superficial and perforating veins of the lower limb.

 

THERACLION and lead investigator Alfred Obermayer, M.D., vascular surgeon at the St. Joseph Hospital in Vienna, director of the Karl Landsteiner Institute for Functional Phlebology – Melk, Austria presented the preliminary results of the first clinical trial on Theraclion’s Echotherapy (also known as High Intensity Focused Ultrasound, HIFU) in the treatment of insufficient superficial and perforating veins of the lower limb.

 

Read the press release

Print Friendly